Y-mAbs Therapeutics, Inc. (YMAB)
NASDAQ: YMAB · Real-Time Price · USD
4.410
-0.400 (-8.32%)
Mar 31, 2025, 1:43 PM EDT - Market open
Y-mAbs Therapeutics Market Cap
Y-mAbs Therapeutics has a market cap or net worth of $199.41 million as of March 31, 2025. Its market cap has decreased by -71.24% in one year.
Market Cap
199.41M
Enterprise Value
140.69M
1-Year Change
-71.24%
Ranking
Category
Stock Price
$4.41
Market Cap Chart
Since September 21, 2018, Y-mAbs Therapeutics's market cap has decreased from $796.74M to $199.41M, a decrease of -74.97%. That is a compound annual growth rate of -19.14%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |